Literature DB >> 27837440

Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis.

Xiaoqin He1,2, Jie Li3, Bin Wang1, Qiuming Yao1, Ling Li1, Ronghua Song1, Xiaohong Shi1, Jin-An Zhang4.   

Abstract

BACKGROUND: Diabetes self-management education is an essential part of diabetes care, but its impact on all-cause mortality risk of type 2 diabetes patients is unclear. A systematic review and meta-analysis aiming to elucidate the impact of diabetes self-management education on all-cause mortality risk of type 2 diabetes patients was performed.
METHODS: Randomised controlled trials were identified though literature search in Medline, Embase, CENTRAL, conference abstracts, and reference lists. Only randomised controlled trials comparing diabetes self-management education with usual care in type 2 diabetes patients and reporting outcomes after a follow-up of at least 12 months were considered eligible. Risk ratios with 95 %CIs were pooled. This study was registered at PROSPERO with the number of CRD42016043911.
RESULTS: 42 randomised controlled trials containing 13,017 participants were included. The mean time of follow-up was 1.5 years. There was no heterogeneity among those included studies (I 2 = 0 %). Mortality occurred in 159 participants (2.3 %) in the diabetes self-management education group and in 187 (3.1 %) in the usual care group, and diabetes self-management education significantly reduced risk of all-cause mortality in type 2 diabetes patients (pooled risk ratios : 0.74, 95 %CI 0.60-0.90, P = 0.003; absolute risk difference: -0.8 %, 95 %CI -1.4 to -0.3). Both multidisciplinary team education and nurse-led education could significantly reduce mortality risk in type 2 diabetes patients, and the pooled risk ratios were 0.66 (95 %CI 0.46-0.96, P = 0.02; I 2 = 0 %) and 0.64 (95 % CI 0.47- 0.88, P = 0.005; I 2 = 0 %), respectively. Subgroup analyses of studies with longer duration of follow-up (≥1.5 years) or larger sample size (≥300) also found a significant effect of diabetes self-management education in reducing mortality risk among type 2 diabetes. Significant effect of diabetes self-management education in reducing mortality risk was also found in those patients receiving diabetes self-management education with contact hours more than 10 h (pooled risk ratio: 0.60, 95 %CI 0.44-0.82, P = 0.001; I 2 = 0 %), those receiving repeated diabetes self-management education (pooled RR: 0.71, P = 0.001; I 2 = 0 %), those receiving diabetes self-management education using structured curriculum (pooled risk ratio: 0.72, P = 0.01; I 2 = 0 %) and those receiving diabetes self-management education using in-person communication (pooled risk ratio: 0.75, P = 0.02; I 2 = 0 %). The quality of evidence for the effect of diabetes self-management education in reducing all-cause mortality risk among type 2 diabetes patients was rated as moderate according to the Grading of Recommendations Assessment, Development, and Evaluation method, and the absolute risk reduction of all-cause mortality of type 2 diabetic patients by diabetes self-management education was estimated to be 4 fewer per 1000 person-years (from 1 fewer to 6 fewer).
CONCLUSIONS: The available evidence suggests that diabetes self-management education can reduce all-cause mortality risk in type 2 diabetes patients. Further clinical trials with longer time of follow-up are needed to validate the finding above.

Entities:  

Keywords:  All-cause mortality; Diabetes self-management education; Meta-analysis; Type 2 diabetes

Mesh:

Year:  2016        PMID: 27837440     DOI: 10.1007/s12020-016-1168-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  97 in total

Review 1.  Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis.

Authors:  Elizabeth Sumamo Schellenberg; Donna M Dryden; Ben Vandermeer; Christine Ha; Christina Korownyk
Journal:  Ann Intern Med       Date:  2013-10-15       Impact factor: 25.391

2.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

3.  Patient Empowerment Programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study.

Authors:  C K H Wong; W C W Wong; Y F Wan; A K C Chan; K L Chung; F W K Chan; C L K Lam
Journal:  Diabetes Obes Metab       Date:  2014-10-20       Impact factor: 6.577

4.  Beyond good intentions: The role of proactive coping in achieving sustained behavioural change in the context of diabetes management.

Authors:  Bart Johan Thoolen; Denise de Ridder; Jozien Bensing; Kees Gorter; Guy Rutten
Journal:  Psychol Health       Date:  2009-03

Review 5.  Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.

Authors:  Steven E Kahn; Mark E Cooper; Stefano Del Prato
Journal:  Lancet       Date:  2013-12-03       Impact factor: 79.321

6.  Evaluation of a nurse-care management system to improve outcomes in patients with complicated diabetes.

Authors:  C Barr Taylor; Nancy Houston Miller; Kelly R Reilly; George Greenwald; Darby Cunning; Allison Deeter; Liana Abascal
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

7.  Efficacy of ongoing group based diabetes self-management education for patients with type 2 diabetes mellitus. A randomised controlled trial.

Authors:  Lisbeth Ø Rygg; Marit By Rise; Kjersti Grønning; Aslak Steinsbekk
Journal:  Patient Educ Couns       Date:  2011-05-17

Review 8.  Diabetes: Advances in Diagnosis and Treatment.

Authors:  David M Nathan
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

9.  Group education for obese patients with type 2 diabetes: greater success at less cost.

Authors:  S R Heller; P Clarke; H Daly; I Davis; D K McCulloch; S P Allison; R B Tattersall
Journal:  Diabet Med       Date:  1988-09       Impact factor: 4.359

10.  Effectiveness of a Peer Support Programme versus Usual Care in Disease Management of Diabetes Mellitus Type 2 regarding Improvement of Metabolic Control: A Cluster-Randomised Controlled Trial.

Authors:  Tim Johansson; Sophie Keller; Henrike Winkler; Thomas Ostermann; Raimund Weitgasser; Andreas C Sönnichsen
Journal:  J Diabetes Res       Date:  2015-12-20       Impact factor: 4.011

View more
  44 in total

Review 1.  May the force be with you: why resistance training is essential for subjects with type 2 diabetes mellitus without complications.

Authors:  Roberto Codella; Marta Ialacqua; Ileana Terruzzi; Livio Luzi
Journal:  Endocrine       Date:  2018-05-05       Impact factor: 3.633

2.  Anti-diabetic agents and heart health: how to use new diabetes medications in a global strategy for the prevention of cardiovascular complications in type 2 diabetes.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Colomba Falcone
Journal:  Ann Transl Med       Date:  2018-05

3.  12th Roche Diabetes Care Network Meeting: April 11-13, 2019, Copenhagen, Denmark.

Authors:  Christopher G Parkin; Christine Zepezauer; Rolf Hinzmann
Journal:  Diabetes Technol Ther       Date:  2020-01-14       Impact factor: 6.118

Review 4.  Japanese Clinical Practice Guideline for Diabetes 2019.

Authors:  Eiichi Araki; Atsushi Goto; Tatsuya Kondo; Mitsuhiko Noda; Hiroshi Noto; Hideki Origasa; Haruhiko Osawa; Akihiko Taguchi; Yukio Tanizawa; Kazuyuki Tobe; Narihito Yoshioka
Journal:  Diabetol Int       Date:  2020-07-24

Review 5.  Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk.

Authors:  Dario Giugliano; Maria Ida Maiorino; Giuseppe Bellastella; Katherine Esposito
Journal:  Endocrine       Date:  2018-01-10       Impact factor: 3.633

6.  Multimedia education program and nutrition therapy improves HbA1c, weight, and lipid profile of patients with type 2 diabetes: a randomized clinical trial.

Authors:  Lubia Velázquez-López; Abril Violeta Muñoz-Torres; Patricia Medina-Bravo; Jenny Vilchis-Gil; Miguel Klϋnder-Klϋnder; Jorge Escobedo-de la Peña
Journal:  Endocrine       Date:  2017-09-18       Impact factor: 3.633

7.  New Paradigm of Personalized Glycemic Control Using Glucose Temporal Density Histograms.

Authors:  Uriel Trahtemberg; Tova Hallas; Yehonatan Segman; Ella Sheiman; Michal Shasha; Kobi Nissim; Yosef Joseph Segman
Journal:  J Diabetes Sci Technol       Date:  2019-01-08

8.  Role of structured individual patient education in the prevention of vascular complications in newly diagnosed type 2 diabetes: the INdividual Therapeutic Education in Newly Diagnosed type 2 diabetes (INTEND) randomized controlled trial.

Authors:  Adriana Coppola; Livio Luzi; Tiziana Montalcini; Andrea Giustina; Carmine Gazzaruso
Journal:  Endocrine       Date:  2017-09-21       Impact factor: 3.633

9.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetologia       Date:  2018-12       Impact factor: 10.122

10.  Japanese Clinical Practice Guideline for Diabetes 2019.

Authors:  Eiichi Araki; Atsushi Goto; Tatsuya Kondo; Mitsuhiko Noda; Hiroshi Noto; Hideki Origasa; Haruhiko Osawa; Akihiko Taguchi; Yukio Tanizawa; Kazuyuki Tobe; Narihito Yoshioka
Journal:  J Diabetes Investig       Date:  2020-07       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.